Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
---|
08/12/2010 | WO2010088924A1 Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration |
08/12/2010 | WO2010088839A1 Drug membrane sticking to pants for treating prostatic hyperplasia and chronic prostatitis, and process for preparation thereof |
08/12/2010 | WO2010088786A1 Herbal composition having cox-2 and immune activities and preparation method thereof |
08/12/2010 | WO2009109616A8 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40 |
08/12/2010 | US20100204294 Methods For Assessing, Improving, Or Maintaining Urogenital Health in Postmenopausal Woman |
08/12/2010 | US20100204275 N-piperidin-4-ylmethyl-amide derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
08/12/2010 | US20100204224 Azacyclic compounds as inhibitors of sensory neurone specific sodium channels |
08/12/2010 | US20100204222 Pyridopyrimidine derivatives as p13 kinase inhibitors |
08/12/2010 | US20100204185 Phenazopyridine compounds |
08/12/2010 | US20100204182 Ectonucleotidase inhibitors |
08/12/2010 | US20100204158 Combination of splenopentin and thymopentin and the use thereof in medicine |
08/12/2010 | US20100204156 Use of thymopentin as a therapeutic agent |
08/12/2010 | US20100204152 Use of gluten exorphin c : as a therapeutic agent |
08/12/2010 | US20100204131 Use of a peptide as a therapeutic agent |
08/12/2010 | US20100204124 Compositions and Methods for Minimally-Invasive Systemic Delivery of Proteins Including TGF-Beta Superfamily Members |
08/12/2010 | US20100204123 Peripheral Administration of Proteins Including TGF-beta Superfamily Members for Treatment of Systemic Disorders and Disease |
08/12/2010 | US20100204117 Cgrp as a therapeutic agent |
08/12/2010 | US20100204116 Use of calcitonin as anti-angiogenic agent |
08/12/2010 | US20100204115 Use of acetyl- (ala10, 11)-rantes (1-14) and/or calcitonin as anti-angiogenic agents |
08/12/2010 | US20100204104 Fusion proteins containing two tgf-beta binding domains of tgf-beta type ii receptor |
08/12/2010 | US20100204094 Diuretic and natriuretic polypeptides |
08/12/2010 | US20100203628 Novel modified galectin 9 proteins and use thereof |
08/12/2010 | US20100203133 High drug load tablet |
08/12/2010 | CA2751039A1 Pharmaceutical composition for oral administration |
08/12/2010 | CA2741052A1 Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration |
08/11/2010 | EP2216409A1 Albumin fusion proteins |
08/11/2010 | EP2216047A1 Regulator for signaling of toll-like receptor, which comprises cathepsin inhibitor as active ingredient |
08/11/2010 | EP2216031A1 Buffered Compositions for dialysis |
08/11/2010 | EP2216025A2 Use of acylaminoalkenylene-amide derivatives in irritable bowel syndrome and functional dyspepsia |
08/11/2010 | EP2216023A1 Condensed pyridine derivative and use thereof |
08/11/2010 | EP2216021A1 Pharmaceutical composition for treating overactive bladder |
08/11/2010 | EP2214688A2 Management and treatment of benign prostatic hyperplasia |
08/11/2010 | EP2214686A1 Calcium-rich alkaline powder produced from processed molluse shells |
08/11/2010 | EP1911763B1 Compositions for the treatment of gastrointestinal disorders |
08/11/2010 | EP1200106B2 Composition containing extracts of butyrospermum parkii and the use as medicament |
08/11/2010 | EP1150676B1 Acyl derivatives of 4-demethylpenclomedine, use thereof and preparation thereof |
08/11/2010 | CN101801949A Sulfonamides as TRPM8 modulators |
08/11/2010 | CN101801379A CSF-1R inhibitors for treatment of cancer and bone diseases |
08/11/2010 | CN101798300A N-phenylindole methyl substituted bis-benzimidazole derivative and application thereof in reducing blood pressure and the like |
08/11/2010 | CN101797388A Matrix of suppository or paste medicine for treating prostatitis and preparation method thereof |
08/11/2010 | CN101797285A Medical composition for preparing drug for curing nephritis |
08/11/2010 | CN101797005A Preserved fruit capable of tonifying the kidney and arresting spontaneous emission |
08/11/2010 | CN101204532B Medicine for prostate disease and preparation method thereof |
08/11/2010 | CN101006047B TRPV1 agonists, formulations containing them and uses thereof |
08/10/2010 | US7772249 Imidazo[1,2-b]pyridazine compound |
08/10/2010 | US7772210 Cystitis treatment with high dose chondroitin sulfate |
08/10/2010 | US7772001 Determining preferential gene expression pattern in embryonic cells; obtain cells, monitor gene expresion products, incubate with animal growth regulators, monitor gene expresion pattern and differentiation in cells |
08/10/2010 | US7771739 Implantable medical devices comprising semi-crystalline poly(ester-amide) |
08/10/2010 | CA2488592C 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia |
08/10/2010 | CA2473680C Compositions and methods for the modulation of sphingolipid metabolism and/or signaling |
08/10/2010 | CA2467013C Substituted benzopyrans as selective estrogen receptor-beta agonists |
08/10/2010 | CA2447021C Pyridyl cyanoguanidine compounds |
08/10/2010 | CA2440714C Pyrazolopyrimidines as therapeutic agents |
08/10/2010 | CA2391832C Oral dosage forms |
08/10/2010 | CA2249542C Pyrazole derivatives, their preparation and their use in pharmaceuticals |
08/05/2010 | WO2010087709A1 Alanine-glyoxylate aminotransferase therapeutics |
08/05/2010 | WO2010087430A1 N-acyl anthranilic acid derivative or salt thereof |
08/05/2010 | WO2010087425A1 Prostate cancer progression inhibitor and progression inhibition method |
08/05/2010 | WO2010087399A1 Urotensin-ii receptor antagonists |
08/05/2010 | WO2010087244A1 Cyclic amino alcohol compound |
08/05/2010 | WO2010039260A3 Spiperone derivatives and methods of treating disorders |
08/05/2010 | WO2010012459A3 A process for the preparation of solifenacin salts and their inclusion into pharmaceutical dosage forms |
08/05/2010 | WO2003060149A9 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
08/05/2010 | US20100197803 Method for obtaining a sequoyitol-containing extract from a plant of the genus of trifolium, leguminosae or ginkoaceae and uses thereof |
08/05/2010 | US20100197744 Organic Compounds |
08/05/2010 | US20100197721 PYRROLO [3, 4-h] ISOQUINOLINE COMPOUNDS AND METHODS FOR MODULATING GATED ION CHANNELS |
08/05/2010 | US20100197710 Methods Of Activating IRS-1 And AKT |
08/05/2010 | US20100197614 Treatment of urinary tract infections with a mixture of saponin and an antibiotic |
08/05/2010 | US20100196518 Method and Device for the Treatment of Water for Purposes Conducive to Good Health |
08/05/2010 | US20100196508 Method and composition for supplementation of nutritional deficiencies in renal patients |
08/05/2010 | US20100196459 Therapeutic formulations containing venom or venom anti-serum either alone or in combination for the therapeutic prophylaxis and therapy of neoplasms |
08/05/2010 | US20100196443 Use of cordyceps species or extract thereof in the egg production |
08/05/2010 | US20100196399 LDL Receptor-Related Proteins 1 and 2 and Treatment of Bone or Cartilage Conditions |
08/05/2010 | US20100196355 Immunophilin Ligands and Methods for Modulating Immunophilin and Calcium Channel Activity |
08/05/2010 | US20100196345 Production of high mannose proteins in plant culture |
08/05/2010 | US20100196340 Lactid acid bacteria as priobiotic strains and compositions containing same |
08/05/2010 | CA2750811A1 Alanine-glyoxylate aminotransferase therapeutics |
08/05/2010 | CA2750452A1 N-acyl anthranilic acid derivative or salt thereof |
08/04/2010 | EP2213743A1 Albumin fusion proteins |
08/04/2010 | EP2213675A1 Pyridooxazepine derivative and use thereof |
08/04/2010 | EP2211890A1 Methods of treating urogenital-neurological disorders using modified clostridial toxins |
08/04/2010 | EP2211875A1 Use of microvesicles (mvs) derived from stem cells for preparing a medicament for endo/epithelial regeneration of damaged or injured tissues or organs, and related in vitro and in vivo methods |
08/04/2010 | EP2211862A2 Csf-1r inhibitors for treatment of cancer and bone diseases |
08/04/2010 | CN1360502B Use of dopamine D3 receptor ligands for producing medicaments for treating kidney disorders |
08/04/2010 | CN101795698A Composition for prevention or treatment of disease associated with the production of autoantibody |
08/04/2010 | CN101795681A Method of preventing nephrocalcinosis |
08/04/2010 | CN101792436A Benzimidazole derivatives used in the treatment of diseases associated with vanilloid receptor 1 |
08/04/2010 | CN101791409A peptide vectors |
08/04/2010 | CN101791389A Perineum medicine membrane underpants for treating prostatic hyperplasia and chronic prostatitis, perineum medicine membrane patch and preparation method |
08/04/2010 | CN101791349A Chinese medicine preparation for treating prostatitis and preparation method thereof |
08/04/2010 | CN101791318A Novel application of bacterial lipopolysaccharides |
08/04/2010 | CN101791302A Medicinal composition containing sodium ferulate and preparation method thereof |
08/04/2010 | CN101791299A Method for preparing potassium citrate sustained-release tablets |
08/03/2010 | US7767682 Treatment of renal diseases or conditions associated with abnormal ion flux in a mammal such as a human which comprises the administration of a hPPAR gamma modulator or salt or solvate thereof, such as farglitazar or rosiglitazone |
08/03/2010 | US7767679 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
08/03/2010 | US7767676 2-amino-3,6-dihydro-4-dimethyl-amino-6-ethyl-1,3,5-triazine hydrochloride; advanced glycosylation end-products inhibitor;antidiabetic, insulin resistance, neurodegenerative disorders, renal complications, atherosclerosis, angiopathy |
08/03/2010 | US7767665 1,3-benzothiazinone derivatives and use thereof |
08/03/2010 | US7767207 Interleukin-18 specific immunoglobulins for treatment and prevention of autoimmune, respiratory, reproductive, heart, connective tissue, liver, bone and arthritic disorders |
08/03/2010 | CA2461426C Imidazo-pyrimidine derivatives as ligands for gaba receptors |
08/03/2010 | CA2459311C 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |